CBGA ameliorates inflammation and fibrosis in nephropathy.

CBD was generally ineffective in reducing inflammatory markers with the possible exception of mRNA of IL-6, IL-2 and ICAM-1, even though this reduction did not reach statistical significance (Fig. 2 b,d,e; blue bars).

also in 111,027 other papers